CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $76,000 | +123.5% | 22,680 | +100.0% | 0.01% | 0.0% |
| Q3 2020 | $34,000 | -34.6% | 11,340 | 0.0% | 0.01% | -43.8% |
| Q2 2020 | $52,000 | +18.2% | 11,340 | 0.0% | 0.02% | -5.9% |
| Q1 2020 | $44,000 | +2.3% | 11,340 | 0.0% | 0.02% | +6.2% |
| Q4 2019 | $43,000 | -28.3% | 11,340 | 0.0% | 0.02% | -33.3% |
| Q3 2019 | $60,000 | +17.6% | 11,340 | -14.7% | 0.02% | +14.3% |
| Q2 2019 | $51,000 | -19.0% | 13,300 | +8.1% | 0.02% | -22.2% |
| Q1 2019 | $63,000 | +162.5% | 12,300 | 0.0% | 0.03% | +107.7% |
| Q4 2018 | $24,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |